| Date Filed | Type | Description |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2019 |
4
| Shaffer James P (Chief Business Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 1,500 shares
@ $7.9475, valued at
$11.9k
|
|
| 03/26/2019 |
4
| Shaffer James P (Chief Business Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 1,301 shares
@ $8.2025, valued at
$10.7k
Granted 1,500 shares
@ $9.9025, valued at
$14.9k
Granted 1,500 shares
@ $8.0325, valued at
$12k
Granted 1,500 shares
@ $7.9475, valued at
$11.9k
Granted 1,500 shares
@ $7.9475, valued at
$11.9k
Granted 50,000 options to buy
@ $14.31, valued at
$715.5k
|
|
| 03/16/2018 |
4
| Shaffer James P (Chief Business Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 60,000 options to buy
@ $9.5, valued at
$570k
|
|
| 03/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/15/2016 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 08/19/2016 |
4
| Shaffer James P (Chief Business Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Bought 3,125 shares
@ $15.7, valued at
$49.1k
|
|
| 06/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/28/2016 |
4
| Shaffer James P (Chief Business Officer) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 60,699 options to buy
@ $15.89, valued at
$964.5k
|
|
| 03/25/2016 |
3
| Shaffer James P (Chief Business Officer) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
| 11/14/2012 |
4
| Shaffer James P (VP & Chief Commercial Officer) has filed a Form 4 on HALOZYME THERAPEUTICS INC|
Txns:
| Bought 20,000 shares
@ $5.22, valued at
$104.4k
|
|
| 12/12/2011 |
3
| Shaffer James P (VP, Chief Commercial Officer) has filed a Form 3 on HALOZYME THERAPEUTICS INC |
| 12/23/2010 |
4
| Shaffer James P (EVP & Chief Commercial Officer) has filed a Form 4 on CLINICAL DATA INC|
Txns:
| Granted 75,000 options to buy
@ $16.54, valued at
$1.2M
|
|
| 08/03/2010 |
4
| Shaffer James P (EVP & Chief Commercial Officer) has filed a Form 4 on CLINICAL DATA INC|
Txns:
| Granted 10,000 options to buy
@ $14.91, valued at
$149.1k
|
|
| 04/09/2010 |
3
| Shaffer James P (EVP & Chief Commercial Officer) has filed a Form 3 on CLINICAL DATA INC |
| 04/09/2010 |
4
| Shaffer James P (EVP & Chief Commercial Officer) has filed a Form 4 on CLINICAL DATA INC|
Txns:
| Granted 20,000 options to buy
@ $18.97, valued at
$379.4k
|
|